ALL PATIENT REFINED DIAGNOSIS RELATED GROUPS: A NEW ADMINISTRATIVE TOOL FOR IDENTIFYING ELDERLY PATIENTS AT RISK OF HIGH RESOURCE CONSUMPTION

2005 ◽  
Vol 53 (1) ◽  
pp. 167-168 ◽  
Author(s):  
Alberto Pilotto ◽  
Carlo Scarcelli ◽  
Luigi Piero D'Ambrosio ◽  
Leandro Cascavilla ◽  
Maria Grazia Longo ◽  
...  
2020 ◽  
Vol 26 (Supplement_1) ◽  
pp. S67-S68
Author(s):  
Jeffrey Berinstein ◽  
Shirley Cohen-Mekelburg ◽  
Calen Steiner ◽  
Megan Mcleod ◽  
Mohamed Noureldin ◽  
...  

Abstract Background High-deductible health plan (HDHP) enrollment has increased rapidly over the last decade. Patients with HDHPs are incentivized to delay or avoid necessary medical care. We aimed to quantify the out-of-pocket costs of Inflammatory Bowel Disease (IBD) patients at risk for high healthcare resource utilization and to evaluate for differences in medical service utilization according to time in insurance period between HDHP and traditional health plan (THP) enrollees. Variations in healthcare utilization according to time may suggest that these patients are delaying or foregoing necessary medical care due to healthcare costs. Methods IBD patients at risk for high resource utilization (defined as recent corticosteroid and narcotic use) continuously enrolled in an HDHP or THP from 2009–2016 were identified using the Truven Health MarketScan database. Median annual financial information was calculated. Time trends in office visits, colonoscopies, emergency department (ED) visits, and hospitalizations were evaluated using additive decomposition time series analysis. Financial information and time trends were compared between the two insurance plan groups. Results Of 605,862 with a diagnosis of IBD, we identified 13,052 patients at risk for high resource utilization with continuous insurance plan enrollment. The median annual out-of-pocket costs were higher in the HDHP group (n=524) than in the THP group (n=12,458) ($1,920 vs. $1,205, p<0.001), as was the median deductible amount ($1,015 vs $289, p<0.001), without any difference in the median annual total healthcare expenses (Figure 1). Time in insurance period had a greater influence on utilization of colonoscopies, ED visits, and hospitalization in IBD patients enrolled in HDHPs compared to THPs (Figure 2). Colonoscopies peaked in the 4th quarter, ED visits peaked in the 1st quarter, and hospitalizations peaked in the 3rd and 4th quarter. Conclusion Among IBD patients at high risk for IBD-related utilization, HDHP enrollment does not change the cost of care, but shifts healthcare costs onto patients. This may be a result of HDHPs incentivizing delays with a potential for both worse disease outcomes and financial toxicity and needs to be further examined using prospective studies.


Diabetes Care ◽  
2004 ◽  
Vol 27 (5) ◽  
pp. 1060-1065 ◽  
Author(s):  
D. T. McCall ◽  
A. Sauaia ◽  
R. F. Hamman ◽  
J. E. Reusch ◽  
P. Barton

2020 ◽  
Vol 16 (1) ◽  
Author(s):  
Ivo Casagranda ◽  
Andrea Ungar ◽  
Carolina Prevaldi ◽  
Pasquale Abete ◽  
Sergio Biagioni ◽  
...  

In aged patients, the most frequent indications for anticoagulation are atrial fibrillation (AF) and venous thromboembolism for stroke and systemic embolism prevention. Despite systemic anticoagulation recommended by current guidelines for patients over 65 years, in clinical practice up to 50 % of elderly patients do not receive maintenance anticoagulation therapy. This is particularly evident in frail subjects at risk of syncopal and not-syncopal fall, fearing intracranial bleeding following a fall. As the risk of bleeding associated with falls is still debated, the boards of the Academy of Emergency Medicine and Care (AcEMC) and the Italian Multidisciplinary Working Group on Syncope (GIMSI), in order to write a consensus document, submitted to a panel of experts eight statement which could represent as many controversial topics for anticoagulant prescription in patients over 75 years. The Delphi method was used to obtain consensus between 15 physicians from different medical specialties; some of them were expert in syncope management and worked in a Syncope Unit. All had experience in prescribing oral anticoagulation. A questionnaire was sent on the appropriateness of oral anticoagulation in eight clinical situations where the risk of fall is present (frailty, cognitive impairment, previous falls, absence of caregiver, chronic renal impairment, nonvalvular AF with HAS-BLED score ≥3 or CHA2DS2-VASc score ≥3). All experts completed the questionnaire within three rounds and the consensus was reached on many but not all statements, leaving room for debate on some clinical situations. The consensus document gives useful advice for elderly patients’ management, who need oral anticoagulant therapy but are at risk of syncopal or not-syncopal fall. Nonetheless, there are some unresolved issues where an individual decision should be taken by the physician in agreement with the patient.


2014 ◽  
Vol 58 ◽  
pp. 43-46 ◽  
Author(s):  
Claudia Basile ◽  
David Della-Morte ◽  
Francesco Cacciatore ◽  
Gaetano Gargiulo ◽  
Gianluigi Galizia ◽  
...  

2013 ◽  
Vol 27 (4) ◽  
pp. 487-492 ◽  
Author(s):  
Ming-hua Chen ◽  
Yan Liao ◽  
Peng-fei Rong ◽  
Rong Hu ◽  
Guo-xin Lin ◽  
...  

Author(s):  
Natalie Flaks‐Manov ◽  
Efrat Shadmi ◽  
Rina Yahalom ◽  
Henia Perry‐Mezre ◽  
Ran Balicer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document